Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Recruiting · NCT06394232 · Registry updated 2024-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. | Geographic Atrophy, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, age-related macular degeneration, eye disorder, macular degeneration, nervous system disorder, retinal degeneration, retinal disorder, vision disorder | Recruiting | Phase 1 / Phase 2 | 2024-09-24 | NCT06394232 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eyestem Research Pvt. Ltd. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| All India Institute of medical Sciences | Delhi | India | 3 |
| L V Prasad Eye Institute | Hyderabad | India | 2 |
| Shri Ganapati Netralaya | Jālna | India | 1 |